Drawing for PROTEOMICROARRAY

USPTO serial 77845405

PROTEOMICROARRAY

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BELL, MARLENE D
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PROTEOMICROARRAY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Assays for research purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Chemicals used in the manufacture of fabric or textiles; Diagnostic reagents for clinical or medical laboratory use; Kit comprising of regeneration solution, serum samples and sensor chips for scientific useACTIVE—
005Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluidsACTIVE—
009Laboratory apparatus and chromatography systems for use in protein purification; Laboratory apparatus and instruments, namely, pre-packed columns for use in separation and purification; Plates, glass slides or chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; Scientific apparatus and instruments, namely, chromatography columns for use in purification in the laboratory and parts and fittings thereforACTIVE—
042Blood analysis services; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; DNA analysis services; Genetic testing of laboratory animals for research purposes; Providing laboratory research services in the field of gene expression, namely, cancer biologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 13, 2010MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 13, 2010ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 11, 2010NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 16, 2010NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 16, 2010PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 9, 2010PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Feb 9, 2010ALIEASSIGNED TO LIE—
Jan 14, 2010CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 12, 2010XAECEXAMINER'S AMENDMENT ENTERED—
Jan 12, 2010GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 12, 2010GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 12, 2010CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 11, 2010DOCKASSIGNED TO EXAMINER—
Oct 16, 2009MPMKNOTICE OF PSEUDO MARK MAILED—
Oct 15, 2009NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 13, 2009NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance